{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:32:48Z","timestamp":1761863568192,"version":"3.40.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.cjca.2016.01.032","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T08:14:35Z","timestamp":1461917675000},"page":"1074-1081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Primary Prevention of Cardiovascular Disease in Older Adults"],"prefix":"10.1016","volume":"32","author":[{"given":"Arden R.","family":"Barry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deirdre E.","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0708-7957","authenticated-orcid":false,"given":"Michelle M.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2016.01.032_bib1","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1001\/jamainternmed.2014.4758","article-title":"Underrepresentation of women, elderly patients, and racial minorities in the randomized trials used for cardiovascular guidelines","volume":"174","author":"Sardar","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cjca.2016.01.032_bib2","doi-asserted-by":"crossref","first-page":"e33559","DOI":"10.1371\/journal.pone.0033559","article-title":"Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs","volume":"7","author":"Konrat","year":"2012","journal-title":"PLoS One"},{"issue":"suppl 2","key":"10.1016\/j.cjca.2016.01.032_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2016.01.032_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0828-282X(09)70715-9","article-title":"2009 Canadian Cardiovascular Society\/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult \u2013 2009 recommendations","volume":"25","author":"Genest","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2016.01.032_bib5","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jamainternmed.2015.4302","article-title":"Statin use in very elderly individuals, 1999-2012","volume":"175","author":"Johansen","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cjca.2016.01.032_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jvs.2008.04.057","article-title":"Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study","volume":"48","author":"Al-Omran","year":"2008","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2016.01.032_bib7","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2016.01.032_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2016.01.032_bib9","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.jacc.2013.07.069","article-title":"Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis","volume":"62","author":"Savarese","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.cjca.2016.01.032_bib10","first-page":"CD003160","article-title":"Statins for prevention of dementia","author":"McGuinness","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cjca.2016.01.032_bib11","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7326\/0003-4819-159-10-201311190-00007","article-title":"Statins and cognitive function: a systematic review","volume":"159","author":"Richardson","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2016.01.032_bib12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.mayocp.2013.07.013","article-title":"Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects","volume":"88","author":"Swiger","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cjca.2016.01.032_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1741-7015-12-51","article-title":"Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis","volume":"12","author":"Macedo","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.cjca.2016.01.032_bib14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11606-014-3115-3","article-title":"Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials","volume":"30","author":"Ott","year":"2015","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.cjca.2016.01.032_bib15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cjca.2011.05.007","article-title":"Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference","volume":"27","author":"Mancini","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2016.01.032_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2016.01.032_bib17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","article-title":"Adherence with statin therapy in elderly patients with and without acute coronary syndromes","volume":"288","author":"Jackevicius","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2016.01.032_bib18","doi-asserted-by":"crossref","first-page":"52C","DOI":"10.1016\/j.amjcard.2005.12.010","article-title":"Statin safety: a systematic review","volume":"97","author":"Law","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2016.01.032_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.11622\/smedj.2013044","article-title":"Cytochrome P450 drug interactions with statin therapy","volume":"54","author":"Goh","year":"2013","journal-title":"Singapore Med J"},{"key":"10.1016\/j.cjca.2016.01.032_bib20","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1592\/phco.26.11.1601","article-title":"Role of P-glycoprotein in statin drug interactions","volume":"26","author":"Holtzman","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cjca.2016.01.032_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11883-015-0495-8","article-title":"Red yeast rice for the treatment of dyslipidemia","volume":"17","author":"Burke","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.cjca.2016.01.032_bib22","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamainternmed.2015.0289","article-title":"Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial","volume":"175","author":"Kutner","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cjca.2016.01.032_bib23","unstructured":"ClinicalTrials.gov. A Clinical Trial of STAtin Therapy For Reducing Events in the Elderly (STAREE). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02099123. Accessed November 27,\u00a02015."},{"key":"10.1016\/j.cjca.2016.01.032_bib24","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/01.cir.0000441139.02102.80","article-title":"Heart disease and stroke statistics\u20142014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2016.01.032_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.304.6824.405","article-title":"Medical research council trial of treatment of hypertension in older adults: principal results","volume":"304","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2016.01.032_bib26","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2016.01.032_bib27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.284.4.465","article-title":"Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP)","volume":"284","author":"Perry","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2016.01.032_bib28","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/j.1532-5415.2008.01948.x","article-title":"Lower systolic blood pressure is associated with greater mortality in people aged 85 and older","volume":"56","author":"Molander","year":"2008","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.cjca.2016.01.032_bib29","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2016.01.032_bib30","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2016.01.032_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cjca.2015.02.016","article-title":"The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension","volume":"31","author":"Daskalopoulou","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2016.01.032_bib32","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2016.01.032_bib33","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-based guidelines for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2016.01.032_bib34","first-page":"S1","article-title":"Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"37","year":"2013","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.cjca.2016.01.032_bib35","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2016.01.032_bib36","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1001\/jama.2014.15690","article-title":"Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial","volume":"312","author":"Ikeda","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2016.01.032_bib37","unstructured":"ClinicalTrials.gov. Aspirin in reducing events in the elderly (ASPREE). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01038583. Accessed November 27,\u00a02015."},{"key":"10.1016\/j.cjca.2016.01.032_bib38","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cjca.2010.12.015","article-title":"The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines","volume":"27","author":"Bell","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2016.01.032_bib39","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/CIRCULATIONAHA.109.870691","article-title":"Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke","volume":"120","author":"Lightwood","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2016.01.032_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0749-0690(18)30498-1","article-title":"Older adults and smoking","volume":"8","author":"LaCroix","year":"1992","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.cjca.2016.01.032_bib41","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/aje\/kwi027","article-title":"Smoking cessation and mortality from cardiovascular disease among Japanese men and women: the JACC study","volume":"161","author":"Iso","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cjca.2016.01.032_bib42","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1136\/bjsports-2014-094306","article-title":"Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged \u226560 years: a systematic review and meta-analysis","volume":"49","author":"Hupin","year":"2015","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.cjca.2016.01.032_bib43","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/01.CIR.0000055315.79177.16","article-title":"Cardiac benefits of fish consumption may depend on the type of fish meat consumed: the Cardiovascular Health Study","volume":"107","author":"Mozaffarian","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2016.01.032_bib44","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2016.01.032_bib45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.diabres.2013.11.025","article-title":"The prognostic role of body mass index on mortality amongst the middle-aged and elderly: a competing risk analysis","volume":"103","author":"Ghaem Maralani","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.cjca.2016.01.032_bib46","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1532-5415.2007.01170.x","article-title":"Association between body mass index and mortality in an 80-year-old population","volume":"55","author":"Takata","year":"2007","journal-title":"J\u00a0Am Geriatr Soc"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X16000933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X16000933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T00:18:26Z","timestamp":1567815506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X16000933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0828282X16000933"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2016.01.032","relation":{},"ISSN":["0828-282X"],"issn-type":[{"type":"print","value":"0828-282X"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Prevention of Cardiovascular Disease in Older Adults","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2016.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}